Cellular Goods explains how cannabinoids such as CBG and CBD have potent anti- inflammatory and antioxidant properties that are capable of preventing skin inflammation
The anti-ageing products market is projected to reach $47.8 billion by 2027. Until now, this burgeoning segment has been dominated by active ingredients like ascorbic acid (vitamin C), retinoids, and α- and β-hydroxy acids.
Yet despite their proven efficacy for addressing signs of ageing skin, these ingredients are notorious for causing irritation and photosensitivity, particularly in the case of retinoids and exfoliating acids. For the 50-60% of men and 60-70% of women who report some degree of sensitive skin, these side-effects can hinder long-term use of these ingredients and, in the short-term, lead to a frustrating trialand-error experiment.
Herein lies the exciting promise of cannabinoids as active skincare ingredients. Generally speaking, the vast majority of research conducted to date has focused on cannabidiol (CBD) and δ9-tetrahydrocannabinol (THC), as these are the most abundant and readily available cannabinoids produced by the plant species Cannabis Sativa L.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
